Drug · DIN 02260638
EBIXA
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since July 23, 2026; first marketed December 16, 2004.
- Drug Identification Number (DIN)
- 02260638
- Company (DIN owner)
- Lundbeck Canada IncSt-Laurent, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Memantine N06DX01
- Class
- Human
- Record last updated
- July 23, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| MEMANTINE HYDROCHLORIDE | 10 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- December 8, 2004: NOC 5987New Drug Submission (NDS)